


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-9.99%
+4.23%
+18.65%
-15.20%
+5.13%
ABBV
AbbVie
$220.43
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Investors confidence is positive
ABBV Price Performance
$228.49 (-3.53%)
$211.96 (+4.00%)
$212.56 (+3.70%)
$193.45 (+13.95%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity

Investors confidence is positive

Pays a reliable dividend
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
ABBV Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ABBV Street Sentiment is extremely bullish and have positive views on the near-term outlook
ABBV has Low risk level

Average key support and resistance price levels
PFE
26.10
+0.93%
SNY
46.20
+0.94%
MRK
108.34
+1.35%
LLY
1024.14
+0.03%
NVS
148.91
0.00%
What is ABBV current stock price?
What are ABBV stock strengths?
What is ABBV Risk Level?
What is ABBV market cap and volume?
What is ABBV current Stock IQ?
Should I buy ABBV stock right now?
Is ABBV a Strong Buy right now?
What does a 'Strong Buy' rating mean for ABBV?
What does a 'Strong Sell' rating mean for ABBV?
What factors influence ABBV's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-9.99%
+4.23%
+18.65%
-15.20%
+5.13%
ABBV
AbbVie
Current Price
$220.43
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Investors confidence is positive
Linked to ABBV
PFE
26.10
+0.93%
SNY
46.20
+0.94%
MRK
108.34
+1.35%
LLY
1024.14
+0.03%
NVS
148.91
0.00%

ABBV Price Performance
$228.49 (-3.53%)
$211.96 (+4.00%)
$212.56 (+3.70%)
$193.45 (+13.95%)
ABBV Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity

Investors confidence is positive

Pays a reliable dividend
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
ABBV Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ABBV Street Sentiment is extremely bullish and have positive views on the near-term outlook
ABBV has Low risk level

Average key support and resistance price levels
Overall Wall Street Rating
BUY
Jan 27, 2026
Price Target Raised
Buy
Jan 06, 2026
Price Target Raised
Buy
Morgan Stanley
Dec 13, 2025
Reiterate
Overweight
Morgan Stanley
Dec 11, 2025
Upgrade
on ABBV
Piper Sandler
Dec 10, 2025
Upgrade
Outperform
HSBC
Dec 10, 2025
Upgrade
Buy
HSBC
ABBV Stock IQ
ABBV Latest Analysis
AbbVie (ABBV) Dips More Than Broader Market: What You Should Know. In the most recent trading session AbbVie (ABBV) closed at $218.87 indicating a -2.26% shift from the previous trading day.
Wed Jan 28, 2026
Why AbbVie Stock Trounced the Market in 2025. Key PointsThe pharmaceutical sector mainstay has built an impressive and resilient portfolio.
Wed Jan 28, 2026
AbbVie (ABBV) Reports Next Week: Wall Street Expects Earnings Growth. AbbVie (ABBV) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wed Jan 28, 2026
AbbVie SLB Amphenol And More On CNBCs Final Trades. On CNBC'.s “.Halftime Report Final Trades”. Jason Snipe founder and chief investment officer of Odyssey Capital Advisors said he likes ) and recommended staying long on the stock.As per the recent news AbbVie on Jan. 12 announced a voluntary agreement with the Trump administration to advance access and affordability further. AbbVie said it will provide low prices in Medicaid while pledging $100 billion in United States-based resea
Wed Jan 28, 2026
Is the Options Market Predicting a Spike in AbbVie Stock?. Investors need to pay close attention to ABBV stock based on the movements in the options market lately.
Tue Jan 27, 2026
Berenberg Grows More Confident in AbbVie (ABBV) on Skyrizi and Rinvoq Momentum. AbbVie Inc. (NYSE:ABBV) is included among the 15 Best S&.P 500 Dividend Stocks to Buy in 2026. On January 20 Berenberg raised its price target on AbbVie Inc. (NYSE:ABBV) to $275 from $270 while keeping a Buy rating on the stock. The firm said it is feeling more confident about AbbVies outlook especially after lifting [….]
Tue Jan 27, 2026
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It. AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore it is wise to be aware of the facts that can impact the stocks prospects.
Mon Jan 26, 2026
AbbVie Inc. (ABBV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.
Wed Jan 14, 2026
Wall Street s Look Optimistic About AbbVie (ABBV): Should You Buy?. According to the average brokerage recommendation (ABR) one should invest in AbbVie (ABBV). It is debatable whether this highly sought-after metric is effective because Wall Street analysts recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Wed Jan 14, 2026
Ex-Dividend Reminder: AbbVie Dime Community Bancshares and MidWestOne Financial Group. Looking at the universe of stocks we cover at Dividend Channel on 1/16/26 AbbVie Inc (Symbol: ABBV) Dime Community Bancshares Inc (Symbol: DCOM) and MidWestOne Financial Group Inc. (Symbol: MOFG) will all trade ex-dividend for their respective upcoming dividends. AbbVie Inc
Wed Jan 14, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ABBV Stock trends
ABBV Stock performance
ABBV Stock analysis
ABBV investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.